Search - tctmd.com

Displaying 61 - 80 of 87

Sort: Relevancy | Date

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Conference News TCT 2015

Use of LAA Occlusion in Low-Risk Patients Debated

Todd Neale

October 11, 2015

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

News Daily News

Un Meta Análisis Revela que Watchman sigue Sin ser Inferior a Warfarina y Da Buenos Resultados de Seguridad

Yael L. Maxwell

June 17, 2015

News Daily News

After Years of Scrutiny, Watchman Ready for Prime Time

April 03, 2015

News Daily News

Tras Años de Análisis, Watchman está Listo para Salir a Escena

April 03, 2015

News Daily News

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Caitlin E. Cox

November 19, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

July 03, 2014

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

News Conference News ESC 2013

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

Yael L. Maxwell

September 02, 2013

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

News Daily News

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

Yael L. Maxwell

May 17, 2013

News Daily News

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

Yael L. Maxwell

April 12, 2013

News Daily News

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

Yael L. Maxwell

April 12, 2013

News Conference News ACC 2013

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

Yael L. Maxwell

March 08, 2013

News Daily News

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

Jason Kahn

February 28, 2013

News Daily News

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Jason Kahn

February 28, 2013

Advertisement

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

Use of LAA Occlusion in Low-Risk Patients Debated

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Un Meta Análisis Revela que Watchman sigue Sin ser Inferior a Warfarina y Da Buenos Resultados de Seguridad

After Years of Scrutiny, Watchman Ready for Prime Time

Tras Años de Análisis, Watchman está Listo para Salir a Escena

PROTECT AF at 4 Years: LAA Closure Maintains Efficacy Over Warfarin

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

PREVAIL Publicado: Watchman y Warfarina Ofrecen Protección Similar Frente a los ACV en Pacientes con FA

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Pooled Trial, Registry Data Support Watchman for Stroke Prevention in A-fib

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

PROTECT AF: Los Resultados a los 4 Años revelan la Superioridad del Watchman sobre la Warfarina contra la FA

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

ASAP Publicado: Watchman es una Opción Segura para Pacientes con FA No Aptos para tomar Warfarina

Will Watchman PREVAIL? Positive Study Pulled from ACC Meeting

PROTECT AF: Watchman Device Improves Quality of Life in A-fib Patients

PROTECT AF: El Dispositivo Watchman Mejora la Calidad de Vida de Pacientes con Fibrilación Auricular

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content